AHR activation has been associated with multiple beneficial effects in IBD, including modulation of immune responses [73], regulation of inflammation via NF‐κB signaling inhibition [74], and attenuation of cytokine‐induced inflammatory signaling [75]. This evidence concerns the gene NFKB1 and inflammatory bowel disease.